Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Effective September 5, Lilly Bio-Medicines Will Split Into Two Business Units: Lilly Neuroscience And Lilly Immunology
Eli Lilly and Company (NYSE:LLY) today announced executive leadership changes and the creation of neuroscience and immunology business units. These changes will increase Lilly's focus on introducing breakthrough new
FDA Clears Use Of Eli Lilly’s Insulin With Insulet’s Infusion Pumps
The FDA has approved the use of Eli Lilly And Co’s (NYSE:LLY) Lyumjev (insulin lispro-aabc injection) 100 units/mL with Insulet Corporation’s (NASDAQ:PODD) insulin management…
Innovent’s Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Innovent Biologics Inc (OTC:IVBIY) has announced topline results from Phase 3 ORIENT-16 study evaluating sintilimab, meeting the primary endpoint of overall…
Lilly’s Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Eli Lilly And Co’s (NYSE:LLY) lebrikizumab ADvocate 1 and ADvocate 2 Phase 3 clinical trials met primary and all key…
Insulet Announces FDA Clearance of Lyumjev Rapid-Acting Insulin for Use with Omnipod® Products in the United States
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced FDA clearance for use of Eli Lilly and Company’s
Eli Lilly Announces FDA Approves Lyumjev100 Units/Ml For Use In Insulin Pumps
The U.S. Food and Drug Administration (FDA) has approved an expanded label for Eli Lilly and Company's (NYSE:LLY) rapid-acting insulin, Lyumjev® (insulin lispro-aabc injection) 100 units/mL indicated to
Unusual Options Activity Insight: Eli Lilly
On Wednesday, shares of Eli Lilly (NYSE:LLY) saw unusual options activity. After the option alert, the stock price moved down to $266.52.
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.